MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 18, 2009; DOI: 10.1124/mol.108.054296


0026-895X/09/7505-1222-1230$20.00
Mol Pharmacol 75:1222-1230, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.054296v1
75/5/1222    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldenstein, B. L.
Right arrow Articles by Doze, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldenstein, B. L.
Right arrow Articles by Doze, V. A.

Regulator of G Protein Signaling Protein Suppression of G{alpha}o Protein-Mediated {alpha}2A Adrenergic Receptor Inhibition of Mouse Hippocampal CA3 Epileptiform Activity

Brianna L. Goldenstein, Brian W. Nelson, Ke Xu, Elizabeth J. Luger, Jacquline A. Pribula, Jenna M. Wald, Lorraine A. O'Shea1, David Weinshenker, Raelene A. Charbeneau, Xinyan Huang, Richard R. Neubig, and Van A. Doze

Department of Pharmacology, Physiology and Therapeutics, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, North Dakota (B.L.G., B.W.N., K.X., E.J.L., J.A.P., J.M.W., L.A.O., V.A.D.); Department of Human Genetics, Emory University, Atlanta, Georgia (D.W.); and Department of Pharmacology, University of Michigan, Medical School, Ann Arbor, Michigan (R.A.C., X.H., R.R.N.)

Activation of G protein-coupled {alpha}2 adrenergic receptors (ARs) inhibits epileptiform activity in the hippocampal CA3 region. The specific mechanism underlying this action is unclear. This study investigated which subtype(s) of {alpha}2ARs and G proteins (G{alpha}o or G{alpha}i) are involved in this response using recordings of mouse hippocampal CA3 epileptiform bursts. Application of epinephrine (EPI) or norepinephrine (NE) reduced the frequency of bursts in a concentration-dependent manner: (-)EPI > (-)NE >>> (+)NE. To identify the {alpha}2AR subtype involved, equilibrium dissociation constants (pKb) were determined for the selective {alpha}AR antagonists atipamezole (8.79), rauwolscine (7.75), 2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane hydrochloride (WB-4101; 6.87), and prazosin (5.71). Calculated pKb values correlated best with affinities determined previously for the mouse {alpha}2AAR subtype (r = 0.98, slope = 1.07). Furthermore, the inhibitory effects of EPI were lost in hippocampal slices from {alpha}2AAR-but not {alpha}2CAR-knockout mice. Pretreatment with pertussis toxin also reduced the EPI-mediated inhibition of epileptiform bursts. Finally, using knock-in mice with point mutations that disrupt regulator of G protein signaling (RGS) binding to G{alpha} subunits to enhance signaling by that G protein, the EPI-mediated inhibition of bursts was significantly more potent in slices from RGS-insensitive G{alpha}oG184S heterozygous (G{alpha}o+/GS) mice compared with either G{alpha}i2G184S heterozygous (G{alpha}i2+/GS) or control mice (EC50 = 2.5 versus 19 and 23 nM, respectively). Together, these findings indicate that the inhibitory effect of EPI on hippocampal CA3 epileptiform activity uses an {alpha}2AAR/G{alpha}o protein-mediated pathway under strong inhibitory control by RGS proteins. This suggests a possible role for RGS inhibitors or selective {alpha}2AAR agonists as a novel antiepileptic drug therapy.


Received for publication December 18, 2008.

Accepted for publication February 18, 2009.

Address correspondence to: Dr. Van A. Doze, Department of Pharmacology, Physiology and Therapeutics, School of Medicine and Health Sciences, University of North Dakota, 501 North Columbia Road, Stop 9037, Grand Forks, ND 58202-9037. E-mail: vdoze{at}medicine.nodak.edu




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
E. E. Icaza, X. Huang, Y. Fu, R. R. Neubig, H. A. Baghdoyan, and R. Lydic
Isoflurane-Induced Changes in Righting Response and Breathing Are Modulated by RGS Proteins
Anesth. Analg., November 1, 2009; 109(5): 1500 - 1505.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics